Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights into methylation patterns and chromatin accessibility dynamics

Daniela Nasif,Sergio Laurito,Sebastian Real,María Teresita Branham
DOI: https://doi.org/10.1007/s10549-024-07343-5
2024-05-08
Breast Cancer Research and Treatment
Abstract:Inhibitor of differentiation 4 (ID4) is a dominant-negative regulator of basic helix–loop–helix (bHLH) transcription factors. The expression of ID4 is dysregulated in various breast cancer subtypes, indicating a potential role for ID4 in subtype-specific breast cancer development. This study aims to elucidate the epigenetic regulation of ID4 within breast cancer subtypes, with a particular focus on DNA methylation and chromatin accessibility.
oncology
What problem does this paper attempt to address?